HCPLive

Top Medical News Today

Renato Delascio Lopes, MD: Living In a New Era of Anticoagulant Therapy
Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.
Experts at the European Society of Cardiology Congress 2016 (ESC) expressed varied opinions on the DANISH trial. Researchers presented that implantable cardioverter-defibrillators (ICDs) do not work for all heart patients.
Not all the news on remote monitoring of cardiac devices was bad at the ESC Congress 2016. Though a UK study had negative findings,Italian researchers said their use reduced office and ED visits and saved patients time and money.
Remote monitoring of heart patients who have implanted heart devices does not appear to help them live longer, a UK study called REM-HF found.
Christopher Granger, MD, Duke University Medical Center also spoke at the European Society of Cardiology COngress 2016 about the issues surrounding patients' tolerability of anticoagulants and other drugs.
Christopher Granger, MD, Professor of Medicine, Director Critical Care Unit, Duke University Medical Center discussed that the European Society of Cardiology (ESC) has grown to be one of the best forums to discuss best practices of cardiovascular care.
Implantable cardioverter-defibrillators are not for all heart failure patients, the DANISH study found.
In the ongoing search for subclinical markers of heart disease, Taiwan researchers found that the diameter of the aortic root is a useful predictor.
Heart failure patients with reduced ejection fraction do better with cardiac interventions, particularly CABG, a meta-analysis of 20 studies found.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$